Group 1 - McKinley Acquisition Corporation closed its initial public offering (IPO) of 15,000,000 units, priced at $10.00 per unit, resulting in gross proceeds of $150,000,000 [1][3] - The units are listed on The Nasdaq Global Market under the symbol "MKLYU", with each unit consisting of one Class A ordinary share and one right [2] - The proceeds from the IPO and a simultaneous private placement were placed in trust, with an audited balance sheet to be included in a Current Report on Form 8-K [3] Group 2 - Clear Street LLC acted as the sole book-running manager for the offering, while Brookline Capital Markets served as co-manager [4] - The underwriters have been granted a 45-day option to purchase up to 2,250,000 additional units at the initial public offering price to cover over-allotments [4] - A registration statement for these securities has been declared effective by the U.S. Securities and Exchange Commission (SEC) [5]

Core Viewpoint - Highview Merger Corp. successfully closed its initial public offering, raising capital through the sale of 23 million units at $10.00 per unit, with additional units sold due to the underwriter's over-allotment option [1][2]. Company Overview - Highview Merger Corp. is a special purpose acquisition company (SPAC) aimed at engaging in mergers, share exchanges, asset acquisitions, and similar business combinations [2]. - The company is led by CEO and CFO David Boris and President Taylor Rettig [2]. Offering Details - The IPO consisted of 23,000,000 units, including 3,000,000 units from the underwriter's over-allotment option, priced at $10.00 per unit [1]. - Each unit includes one Class A ordinary share and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share [1]. - The units are listed on Nasdaq under the ticker symbol "HVMCU," with separate trading expected for Class A shares and warrants under "HVMC" and "HVMCW," respectively [1]. Regulatory Information - A registration statement for these securities was declared effective by the SEC on August 11, 2025 [4].

Group 1 - Bullish, a crypto exchange backed by Peter Thiel, successfully raised over $1 billion in its IPO, with shares more than doubling from the initial offering price of $37 to a peak of about $118 [1][2] - The IPO was priced at $37, exceeding the expected range of $32 to $33, and significantly higher than the initial range of $28 to $31 [2] - Following the IPO, Bullish's market valuation surged from approximately $5.4 billion to over $13 billion shortly after trading began, reaching above $17 billion at its peak [2] Group 2 - Trading for Bullish's stock, listed under the ticker BLSH, was halted multiple times due to volatility, with trading interruptions occurring at 1:02 p.m., 1:12 p.m., and 1:18 p.m. [3] - Major shareholders include Brendan Blumer, who is expected to hold about 30.1% of shares, and Kokuei Yuan, likely holding 26.7% [4] - Investment firms BlackRock and ARK Investment Management have shown interest in purchasing up to $200 million of shares at the IPO price [4]

IPO Performance - Shares jumped 143% from the IPO price [1] - The company raised $1.1 billion in an initial public offering [1] Company Overview - The company is a digital-asset exchange operator [1] - The company owns media outlet CoinDesk [1]

Market Trends - Shares of private equity-backed companies that have done recent IPOs are struggling [1] - Investors are seeking riskier assets like cryptocurrencies and AI [1]

Core Viewpoint - Etoiles Capital Group Co., Ltd has successfully closed the sale of an additional 210,000 Class A ordinary shares at the IPO price of $4.00 per share, raising a total of $6,440,000 from the Offering [1][2]. Group 1: Offering Details - The Offering included the full exercise of the underwriters' over-allotment option and was conducted on a firm commitment basis [1][3]. - Prime Number Capital, LLC served as the representative underwriter and sole book-runner for the Offering [3]. - The gross proceeds from the Offering consist of $5,600,000 from the initial IPO and $6,440,000 from the additional shares sold [1][2]. Group 2: Use of Proceeds - Proceeds from the Offering will be allocated towards business expansion, technology infrastructure, strategic marketing, and general corporate purposes [2]. Group 3: Regulatory Information - A registration statement on Form F-1 was filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on August 7, 2025 [4]. - The final prospectus related to the Offering was also filed with the SEC on August 7, 2025, and is available through various channels [4]. Group 4: Company Overview - Etoiles Capital Group Co., Ltd operates as a Cayman Islands holding company through its Hong Kong subsidiary, providing comprehensive financial advisory and capital markets services [7].

Core Viewpoint - Etoiles Capital Group Co., Ltd has successfully closed the sale of an additional 210,000 Class A ordinary shares at the IPO price of $4.00 per share, raising a total of $6,440,000 in gross proceeds from the Offering [1][2]. Group 1: Offering Details - The Offering included the full exercise of the underwriters' over-allotment option and was conducted on a firm commitment basis [1][3]. - Prime Number Capital, LLC served as the representative underwriter and sole book-runner for the Offering [3]. - The registration statement for the Offering was filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on August 7, 2025 [4]. Group 2: Use of Proceeds - Proceeds from the Offering will be allocated for business expansion, technology infrastructure, strategic marketing, and general corporate purposes [2]. Group 3: Company Overview - Etoiles Capital Group operates as a Cayman Islands holding company through its Hong Kong subsidiary, providing integrated financial advisory, capital markets solutions, and IPO consulting services to corporate clients [7].

Defense manufacturer Czechoslovak Group AS has selected banks to lead its potential initial public offering that could take place as soon as next year, according to people familiar with the matter https://t.co/9S4uT0p43Q ...

Core Viewpoint - Nasus Pharma Ltd. has successfully priced its initial public offering (IPO) of 1,250,000 ordinary shares at $8.00 per share, aiming for gross proceeds of $10 million before expenses [1][4]. Group 1: IPO Details - The IPO consists of 1,250,000 ordinary shares priced at $8.00 each, targeting total gross proceeds of $10 million [1]. - An additional option for underwriters allows them to purchase up to 187,500 ordinary shares within 45 days to cover over-allotments [1]. - The shares are approved for listing on NYSE American under the ticker symbol "NSRX," with trading expected to commence on August 13, 2025 [3]. Group 2: Use of Proceeds - The net proceeds from the IPO will primarily fund the development of the intranasal Epinephrine program, including manufacturing scale-up and additional Phase 2 studies [2]. - Remaining funds will be allocated for general corporate purposes, including working capital and capital expenditures [2]. Group 3: Company Overview - Nasus Pharma is a clinical-stage pharmaceutical company focused on developing innovative intranasal products for emergency medical conditions [6]. - The company's lead product candidate, NS002, is an intranasal powder formulation of Epinephrine designed as a needle-free alternative for anaphylaxis treatment [6]. - The proprietary powder-based intranasal (PBI) technology aims for rapid and reliable drug delivery, utilizing the nasal cavity's vascular network for quick absorption [6].

Group 1 - The Company, Highview Merger Corp., has priced its initial public offering (IPO) at $10.00 per unit, consisting of 20,000,000 units [1] - Each unit includes one Class A ordinary share and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share [1] - The units will be listed on Nasdaq under the ticker symbol "HVMCU" starting August 12, 2025, with separate trading expected for Class A shares and warrants under "HVMC" and "HVMCW" respectively [1] Group 2 - The Company is a special purpose acquisition company (SPAC) aimed at merging or acquiring businesses [2] - Leadership includes CEO and CFO David Boris and President Taylor Rettig [2] Group 3 - Jefferies is the sole book running manager for the offering and has a 45-day option to purchase an additional 3,000,000 units to cover overallotments [3] Group 4 - The offering is conducted via a prospectus, which can be obtained from Jefferies LLC [4] - A registration statement for these securities was declared effective by the SEC on August 11, 2025 [5]